Inogen (INGN) Cash from Operations (2013 - 2026)
Inogen's (INGN) quarterly Cash from Operations came in at 6685000.0 in Q1 2026, up 60.18% year-on-year from 4173309.17 in Q1 2025, and down 608.91% on a QoQ basis from 943000.0 in Q4 2025.
Inogen (INGN) Cash from Operations (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Cash from Operations data on file, last reported at 6685000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 60.18% year-over-year to 6685000.0 in Q1 2026; TTM through Mar 2026 was 1111000.0, a 81.87% increase from a year earlier, with the FY2025 full-year figure at 11216000.0, down 289.65% from the prior year.
- Cash from Operations for Q1 2026 stood at 6685000.0, down from 943000.0 in the prior quarter.
- Over the last five years, Cash from Operations for INGN reached as high as 6992000.0 in Q3 2024 and fell as low as 18098000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 3103117.65 across 5 years, with a median of 3018000.0 in 2024.
- Across the five-year window, Cash from Operations tumbled 732.8% in 2022 and jumped 220.0% in 2024, its largest moves.
- Year by year, Cash from Operations stood at 15482000.0 in 2022, then soared by 79.67% to 3148000.0 in 2023, then rose by 4.13% to 3018000.0 in 2024, then soared by 68.75% to 943000.0 in 2025, then tumbled by 608.91% to 6685000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 6685000.0 in Q1 2026, 943000.0 in Q4 2025, and 2167000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | -6.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.69 Mn |
| Mar 31, 2026 | -6.69 Mn |
| Dec 31, 2025 | -943,000.00 |
| Dec 31, 2025 | -943,000.00 |
| Sep 30, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Mar 31, 2025 | -16.79 Mn |
| Mar 31, 2025 | -16.79 Mn |
| Dec 31, 2024 | -3.02 Mn |
| Dec 31, 2024 | -3.02 Mn |
| Sep 30, 2024 | 6.99 Mn |
| Sep 30, 2024 | 6.99 Mn |
| Jun 30, 2024 | 6.69 Mn |
| Jun 30, 2024 | 6.69 Mn |
| Mar 31, 2024 | -4.75 Mn |
| Mar 31, 2024 | -4.75 Mn |
| Dec 31, 2023 | -3.15 Mn |
| Dec 31, 2023 | -3.15 Mn |